Newlywed Neha Kakkar got a warm welcome at husband Rohanpreet Singh's home. After reaching Rohanpreet Singh's house, Neha Kakkar and Rohanpreet performed post-wedding rituals.
Newlywed Neha Kakkar got a warm welcome at husband Rohanpreet Singh's home. After reaching Rohanpreet Singh's house, Neha Kakkar and Rohanpreet performed post-wedding rituals.
Eilat/Beersheva, Nov 27 (PTI) Jewish outreach movement Chabad has unveiled a plaque at its synagogue in Israel's southern coastal city of Eilat in the memory of six Jews killed in the 26/11 Mumbai terror attacks, demanding that the perpetrators of the carnage be brought to justice.
The best Black Friday GoPro deals for 2020, including all the best GoPro accessories savings
Here’s our list of the latest Apple iPad Pro deals for Black Friday & Cyber Monday 2020, featuring sales on 128GB and 256GB iPad Pro (12.9-inch, 11-inch) Here’s a review of the best Apple iPad Pro tablet deals for Black Friday & Cyber Monday 2020, including savings on 12.9-inch and 11-inch iPad Pros in 256GB and 128GB & WiFi and WiFi + Cellular configurations. Links to the top deals are listed below.Best iPad Pro Deals: * Save up to $350 on the latest iPad Pro 12.9 & 11-inch tablets tablets at Verizon \- deals available on 11 inch & 12.9 inch models * Save up to $100 on the new Apple iPad Pro (12.9-inch, 11-inch & 10.5-inch) at Amazon \- check the latest deals on a wide selection of iPad Pro available in 64GB, 128GB and 256GB storage capacities * Save on the Apple iPad Pro (11.9 & 12-inch) at AT&T \- check live prices on top-rated iPad Pro models and learn how to save up to half off the 7th Gen Apple iPad Best iPad Deals: * Save up to 50% on the latest Apple iPad at AT&T \- Black Friday deals! Learn how to get the iPad 7th Gen 128GB for half off at AT&T * Save up to $350 on Apple iPad, iPad Pro, iPad mini & iPad Air at Verizon \- check the deals on the latest Apple iPad 8th generation, iPad Air 4th generation, iPad Pro and more * Save up to 30% on Apple iPads including iPad Pro, iPad Air & iPad mini at Amazon \- check the live prices on top-rated Apple iPads including iPad Air, iPad Pro, iPad mini and more * Get an iPad 10.2 inch for $99 at Verizon.com \- when you buy one of Verizon’s best iPhones. Save up to $700 on a wide range of Verizon’s latest iPhone models * Save up to $350 on the latest iPad 8th generation model at Verizon \- click the link for latest deals on Apple iPad 2020 (8th generation) available in gold, silver and space gray colors * Save on 8th generation Apple iPads at Amazon \- check deals for the latest 10.2-inch Apple iPads available in 32GB and 128GB storage capacities * Save up to $60 on 10.2” Apple iPads at BHPhotoVideo.com \- see the latest prices on 10.2” iPads available in space gray, silver and gold colors Interested in more deals? Click here to shop the entire range of active deals at Walmart’s Black Friday & Cyber Monday sale and click here to check out Amazon’s live Black Friday & Cyber Monday deals. Spending Lab earns commissions from purchases made using the links provided.About Spending Lab: Spending Lab research and report on online sales events. As an Amazon Associate and affiliate Spending Lab earns from qualifying purchases.Contact: Andy Mathews (firstname.lastname@example.org)
Police struggle to keep control as tens of thousands come to pay respects to the late football legend.
With prices slashed on big-ticket items, the giant retailer’s sale is not one to miss
Despite restrictions, some traditions have continued - including New York City's Thanksgiving parade.
Black Friday Apple iPad Air deals are underway, compare all the top Black Friday & Cyber Monday iPad Air 4th Gen (2020) and 3rd Gen savings on this page Find the latest Apple iPad tablet deals for Black Friday & Cyber Monday 2020, including the 64GB and 256GB iPad Air 3, iPad Air 4 (2020 model), and more iPad Air deals. Links to the latest deals are listed below. Best iPad Air Deals: * Save up to $350 on the Apple iPad Air (4th Gen) at Verizon \- check the latest deals available on the latest 4th generation iPad Air and more * Save up to 30% on Apple iPad Air tablets at Amazon \- check the latest deals on WiFi and WiFi + Cellular models of the Apple iPad Air 4 (2020), iPad Air 3, and more iPad Air models * Save on the Apple iPad Air (2020 model) at AT&T \- check out the latest iPad Air featuring Liquid Retina display, A14 Bionic Chip with Neural Engine, touch ID fingerprint sensor, 12MP back camera and 7MP front camera * Save on the latest Apple iPad Air 4th generation model at Amazon \- the 10.9-inch iPad 4 (2020) is powered by Apple’s fast A14 Bionic chip and works with the Apple Pencil, Magic Keyboard, and Smart Keyboard Folio Best iPad Deals: * Save up to 50% on the latest Apple iPad at AT&T \- Black Friday deals! Learn how to get the iPad 7th Gen 128GB for half off at AT&T * Save up to $350 on Apple iPad, iPad Pro, iPad mini & iPad Air at Verizon \- check the deals on the latest Apple iPad 8th generation, iPad Air 4th generation, iPad Pro and more * Save up to 30% on Apple iPads including iPad Pro, iPad Air & iPad mini at Amazon \- check the live prices on top-rated Apple iPads including iPad Air, iPad Pro, iPad mini and more * Get an iPad 10.2 inch for $99 at Verizon.com \- when you buy one of Verizon’s best iPhones. Save up to $700 on a wide range of Verizon’s latest iPhone models * Save up to $350 on the latest iPad 8th generation model at Verizon \- click the link for latest deals on Apple iPad 2020 (8th generation) available in gold, silver and space gray colors * Save on 8th generation Apple iPads at Amazon \- check deals for the latest 10.2-inch Apple iPads available in 32GB and 128GB storage capacities * Save up to $60 on 10.2” Apple iPads at BHPhotoVideo.com \- see the latest prices on 10.2” iPads available in space gray, silver and gold colors In need of some more deals? Click here to see the entire range of active deals at Walmart’s Black Friday & Cyber Monday sale and click here to browse Amazon’s current Black Friday & Cyber Monday deals. Retail Egg earns commissions from purchases made using the links provided.About Retail Egg: Retail Egg shares e-commerce deals news. As an Amazon Associate and affiliate Retail Egg earns from qualifying purchases.Contact: Andy Mathews (email@example.com)
STRATHROY, Ontario, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its financial results for the three and nine months ended September 30, 2020. The financial statements and management’s discussion and analysis for such period are available on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on Eve & Co's website at www.evecannabis.ca. ABOUT EVE & COEve & Co, through its wholly-owned subsidiary Natural MedCo Ltd. (“NMC”), holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received European Union Good Manufacturing Practice certification. NMC was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 sq. ft. greenhouse located in Strathroy, Ontario.CAUTIONARY NOTESCertain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s expansion, licensing, the expected increase in production capacity, the expanded product lines, the commencement of shipments to Germany, opportunities for growth, the effects of COVID-19, sales, future strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s management’s discussion and analysis for the three and nine months ended September 30, 2020 which is available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law. Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information, please contact:Melinda Rombouts President and Chief Executive Officer Eve & Co Incorporated Telephone: (855) 628-6337 Rory Taylor Interim Chief Financial Officer Eve & Co Incorporated Telephone: (855) 628-6337
The best Black Friday DJI deals for 2020, including all the latest DJI Osmo action camera and Mavic (Air, Pro 2, Mini) & Spark drone savings
Harry Winks has confessed that his 56-yard wonderstrike in Tottenham’s win over Ludogorets was a fluke - but manager Jose Mourinho says he should have claimed he meant it. Spurs strolled to a 4-0 win over the Bulgarian side in Thursday night’s Europa League group stage clash, to move within a point of qualifying for the knockout phase. Summer signing Carlos Vinicius scored his first two goals for the club before Winks’ freakish effort sparked debate.
A seven-year-old girl was killed on Mother's Day as she scooted towards her mum, who was jogging in the park, a court has heard. Emily Jones had gone to Queen’s Park in Bolton with her father Mark Jones on Mother’s Day earlier this year when she had spotted her mum, Sarah Barnes, jogging ahead of them, a jury at Minshull Street Crown Court, Manchester was told. Seven-year-old Emily had been on her scooter at the time and called out to her mother, who was unable to hear her, when a stranger got up from a bench and slit her throat with a craft knife. Eltiona Skana, 30, originally from Albania, is appearing at the hearing by video link from Rampton Hospital in Nottinghamshire. She has pleaded guilty to manslaughter on March 22, on the grounds of diminished responsibility, a partial defence to murder. Michael Brady QC, opening the case for the prosecution, said at around 2.15pm that day Emily's father took her to the park on her scooter. Emily's parents were no longer together but remained on good terms and as was usual, their daughter spent Sundays with her father and they agreed to meet up later at the park. Mr Brady said that when Emily saw her mother running in the park, she said, "Daddy, daddy, I want to go to mum." Her father consented and she scooted off, then as his daughter drew level with the park bench he saw Skana, stand up and move towards Emily. "Also in the park was Eltiona Skana. "She was alone on a bench armed with a craft knife, which she had taken from a pack of three that she had bought earlier that day from a shop in Bolton town centre. "Emily, oblivious of the defendant, had seen her mother running in the distance and was scooting towards her, some yards ahead of her father. "As she scooted along, she was heard to call out to her mother who was unable to hear her because of the distance between them and the fact that Ms Barnes had her headphones on. "Emily's path towards her mum took her past the defendant who, as Emily scooted by, grabbed her and in one movement slit her throat with the craft knife and then threw her to the ground." Mr Brady said there had been “no interaction between Emily and the defendant” and that the wound was “unsurvivable”. Emily's father heard her cry out and thought she had fallen off her scooter. He then heard a woman shout, "She's been stabbed" and saw Skana run away. Mr Brady told the jury: "He cradled Emily from behind and shouted for help.” Meanwhile, Tony Canty and his wife Lynsey, out for a walk in the park with their baby daughter Laurel, had seen Skana manhandling Emily. Mr Canty handed over the baby to his wife and ran after the defendant. He brought her to the ground and straddled her until police arrived. Emily's parents then waited with her while the paramedics tried to save her life. She was rushed by air ambulance to Salford Royal Hospital but Emily had gone into cardiac arrest and with her mother at her bedside she was pronounced dead at 3.56pm. In a statement read to the jury, Emily's father said: "I do not know why this happened. Emily was simply riding her scooter to her mum. I simply can't explain it." After her arrest, Skana was assessed, telling the on-call psychiatrist, "I know I'm a paranoid schizophrenic" and she was detained under the Mental Health Act. Skana was moved to the high-security hospital at Rampton where she told a nurse: “It was premeditated, I waited in a park and picked my victim, I did what I did, then tried to run away.” She also told medics she was "perfectly normal" before coming to the UK and claiming asylum in 2014. Mr Brady said although it is accepted the defendant does have, and has had, mental health difficulties for a number of years, it is for the jury to decide whether this is a case of murder rather than manslaughter. The trial was adjourned until Friday morning.
The latest Black Friday & Cyber Monday Apple iPad deals for 2020, including iPad Air (4th Gen, 2020 release) and iPad Air 3 sales
Black Friday Coach deals have arrived, explore the best Black Friday handbags, purses, shoes & more deals on this page
Chelsea have confirmed that 2,000 fans will provisionally be allowed to return to Stamford Bridge to watch their Premier League match against Leeds United on December 5. Under the Government's new tier system in England to tackle the spread of coronavirus, Brighton, Chelsea, Liverpool and West Ham will be able to allow supporters into their stadiums for their first Premier League matches in December. Chelsea are yet to confirm any details about tickets for the match, while the return of supporters also depends on local authorities granting approval to the scheme.
Islamabad [Pakistan], November 27 (ANI): Pakistan Federal Information Minister Shibli Faraz has threatened Opposition leaders that first information reports (FIRs) will be registered against them if they participate in the Pakistan Democratic Movement ( PDM) rally.
Delhi-Haryana Border, Nov 27 (ANI): Security has been tightened at Singhu border (Haryana-Delhi border) and barricading is also being done, in the wake of farmers' 'Delhi Chalo' protest march. Farmer groups are heading towards Delhi to protest against amended farm laws.
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced their third quarter 2020 financial results. Recent Corporate Highlights: * Q3 2020 revenues were 26% higher than Q3 2019 with a notable increase of 48% from product sales in the current quarter despite the impact of the COVID-19 pandemic. * On September 28, 2020, Kane Biotech Inc. announced that it has entered into an agreement with UK-based veterinary products company, Animalcare Group PLC under which the parties formed STEM Animal Health Inc., a company dedicated to treating biofilm-related ailments in animals. Animalcare is to invest $5 million consisting of $3 million to acquire a one-third equity stake in STEM and $2 million for the rights to commercialize products in the global veterinary markets outside of Americas. * On October 13, 2020, the Company announced that Kevin Cole will assume the role of President and CEO of STEM Animal Health Inc. In this new role Kevin will focus on building STEM into a globally recognized name in the biofilm-targeting technology with an emphasis on developing sales channel and penetrating the growing pet care sector, utilizing STEM’s product line. * On October 28, 2020, the Company announced the launch of a larger consumer product test to further prove the efficacy of the Company’s shampoo on dermatitis and dandruff began on October 14, 2020. This large-scale, multi-product test will focus on US consumers and has a similar design to the consumer trial that was launched earlier this year in Canada. * On November 5, 2020, the Company announced that it had entered into a one year credit agreement with Pivot Financial Inc. for a non-revolving term loan in the aggregate amount of $1,480,000. The credit facility will be used by Kane Biotech for: (i) funding research and development relating to eligible government reimbursable expenditures; (ii) expenses related to STEM Animal Health Inc; and (iii) general working capital purposes. “We are pleased with our progress during the quarter and continue to focus on execution and commercialization of our product portfolio. The STEM Animal Health transaction demonstrates the potential global growth of our animal care products and allows Kane Biotech to become a truly global company, giving us access to new markets and revenue. We continue trials in the US and Canada for our human products and the provisional results look very positive and will allow us to grow that segment going forward with a view to returning shareholder value,” stated Marc Edwards President and Chief Executive Officer of Kane Biotech.Third Quarter 2020 Financial Highlights * Revenue from product sales in the three months ended September 30, 2020 was $286,934, an increase of 48% compared to $194,483 in the three months ended September 30, 2019. This is due to higher online sales and a larger customer base in the current period. * Gross profit for the third quarter of 2020 was $129,156, an increase of 11% compared to $116,322 for the quarter ended September 30, 2019. The increase in gross profit is primarily related to higher product revenues. * Total operating expenses for the quarter ended September 30, 2020 were $1,247,140, an increase of 37% compared to $912,058 for the same period in 2019. The increase in expenses is mostly related to legal costs associated with the Animalcare agreement which was finalized during this period. * Loss from operations and finance costs for the third quarter of 2020 was ($1,030,948) an increase of 25% compared to ($821,554) for the quarter ended September 30, 2019. Detailed financial information about Kane Biotech can be found in its September 30, 2020 Financial Statements and Management Discussion and Analysis on SEDAR and the Company’s website.Conference Call DetailsKane Biotech is pleased to invite all interested parties to participate in a conference call on Monday November 30, 2020 at 4.30pm ET during which time the results will be discussed.Webcast Link: https://edge.media-server.com/mmc/p/ukgs8mo2Participant Dial In: Participant Toll-Free Dial-In Number: (877) 268-9044 Participant International Dial-In Number: (706) 679-2995 Password: 3572374 * International dial-ins available at the reservation confirmation attached Telco Replay (7 Days valid after the live call) Toll Free Encore: 855 859-2056 Toll Encore: 404 537-3406 Password: 3572374 A live and archived audio webcast of the conference call will also be available on the investor relations page of Kane Biotech’s corporate website. www.kanebiotech.com About Kane Biotech Inc.Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (52 patents and patents pending, trade secrets and trademarks) and products developed by the Company's own biofilm research expertise and acquired from leading research institutions. StrixNB™, DispersinB®, Aledex™, bluestem™, bluestem®, silkstem™, goldstem™, coactiv+™, coactive+®, DermaKB™ and DermaKB Biofilm™ are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE" and on the OTCQB Venture Market under the symbol “KNBIF”.For more information, please visit www.kanebiotech.com, or contactMarc EdwardsRay DupuisGraham Farrell Chief Executive OfficerChief Financial OfficerInvestor Relations Kane Biotech IncKane Biotech IncHarbor Access LLC firstname.lastname@example.org@kanebiotech.comGraham.Farrell@HarborAccessllc.com +1 (514) 910-6991+1 (204) 298-2200+1 (416) 842 9003 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking InformationThis press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company’s: (a) financial condition, including lack of significant revenues to date and reliance on equity and other financing; (b) business, including its early stage of development, government regulation, market acceptance for its products, rapid technological change and dependence on key personnel; (c) intellectual property including the ability of the Company to protect its intellectual property and dependence on its strategic partners; and (d) capital structure, including its lack of dividends on its common shares, volatility of the market price of its common shares and public company costs. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by the Company with applicable securities regulatory authorities, available at www.sedar.com. The Company cautions that the foregoing list of factors that may affect future results is not exhaustive.COVID-19 PandemicSince December 31, 2019, the COVID-19 outbreak of the novel strain of coronavirus, SARS-CoV-2, has resulted in a widespread health crisis that has affected economies and financial markets around the world resulting in an economic downturn. The effects of this pandemic on the Company may include decreased customer demand, interruptions to supply chains, manufacturing activities and research and development programs and increased government regulations or interventions. The duration and impact of the COVID-19 outbreak is unknown at this time and it is not possible to reliably estimate the length and severity of these developments nor the impact of these developments on the financial results and condition of the Company in future periods.KANE BIOTECH INC. Selected Financial Results Statement of Comprehensive Income (Loss) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Total Revenue $ 360,603 $286,838 $ 1,084,236 $1,129,385 Gross Profit 129,156 116,322 424,143 409,678 Operating expenses General and administration 869,309 672,239 2,518,869 1,943,701 Research 377,831 239,819 1,063,871 834,462 Total operating expenses 1,247,140 912,058 3,582,740 2,778,163 Loss from operations and finance costs $ (1,030,948) $(821,554) $ (2,900,181) $(2,472,084) Income (loss) and comprehensive income (loss) for the period$ (1,030,948) $(821,554) $ (2,900,181) $196,516 Basic and diluted income (loss) per share for the period $ (0.01) $(0.01) $ (0.03) $- Weighted average shares outstanding - basic 108,613,535 82,966,797 107,191,993 81,075,075 Weighted average shares outstanding - diluted 108,613,536 82,966,797 107,191,993 81,195,329 Statement of Financial Position September 30, December 31, 2020 2019 Cash and cash equivalents $ 1,272,305 $834,128 Other current assets 1,436,023 1,075,297 Non-current assets 2,178,334 846,267 Total Assets $ 4,886,662 $2,755,692 Current liabilities $ 1,850,309 $1,341,653 Non-current liabilities 1,062,576 577,232 Shareholders' equity 1,973,777 836,807 Total liabilities and shareholders' equity $ 4,886,662 $2,755,692 Source: Kane Biotech Inc.
Ontario’s top health professionals say the province is in a “precarious” position where there is some “flattening” of the epidemic curve in certain areas, but situations differ greatly across Ontario.
Black Friday makeup deals for 2020, featuring the best Morphe, ABH & more deals
CALGARY, Alberta, Nov. 26, 2020 (GLOBE NEWSWIRE) -- CORDY OILFIELD SERVICES INC. (the “Corporation” or “Cordy”) (CKK: TSX-V) released today its third quarter 2020 results. Three months ended September 30,Nine months ended September 30, ($ 000's)2020 2019 ($) Change 2020 2019 ($) Change Revenue Environmental Services3,024 3,881 (857)12,557 12,385 172 Heavy Construction60 122 (62)272 414 (142) Corporate- - - 15 5 10 3,084 4,003 (919)12,844 12,804 40 Direct operating expenses Environmental Services2,029 2,855 (826)9,146 9,331 (185) Heavy Construction20 80 (60)118 231 (113) Corporate- - - - - - 2,049 2,935 (886)9,264 9,562 (298) General and administrative expenses Environmental Services269 285 (16)511 587 (76) Heavy Construction0 - 0 2 2 (0) Corporate206 233 (27)628 724 (96) 475 518 (43)1,141 1,313 (172) Operating earnings (loss) Environmental Services726 741 (15)2,900 2,467 433 Heavy Construction40 42 (2)152 181 (29) Corporate(206)(233)27 (613)(719)106 560 550 10 2,439 1,929 510 Depreciation625 477 148 1,742 1,469 273 Finance costs261 198 63 727 598 129 Gain (loss) on disposal- (86)86 - (483)483 Share-based recovery- - - - - - Earnings (loss) before tax(326)(39)(287)(31)345 (376) Income tax expense- - - - - - Net earnings (loss)(326)(39)(287)(31)345 (376) Third Quarter Financial Summary: * Revenue for the three and nine months ended September 30, 2020 down 23% for the quarter but even for the year; * total revenue of $3.1 million for the quarter, a decrease of $0.9 million, or 23% compared to $4.0 million in 2019; * total revenue of $12.8 million year-to-date compared to $12.8 million in 2019. * Operating earnings for the three and nine months ended September 30, 2020 up 2% on the quarter and up 26% for the year; * total operating earnings of $0.56 million for the quarter, a slight increase compared to $0.55 million in 2019; * total operating earnings of $2.4 million, an increase of $0.5 million, or 26% compared to $1.9 million in 2019. * Net (loss) earnings for the three and nine months ended September 30, 2020 down on the quarter and down on the year; * net loss of $0.3 million for the quarter, a decrease of $0.3 million, compared to a net loss of $0.03 million in 2019; * net loss of $0.03 million year to date, a decrease of $0.4 million, compared to net earnings of $0.3 million in 2019. * Canadian Emergency Wages Subsidy (“CEWS”) for the three and nine months ended September 30, 2020 was $0.5 million and $1.1 million respectively; * $0.4 million recognized as reduction to Direct Operation Expenses (“DOE”) and $0.1 million recognized as a reduction to general and administrative (“G&A”) expense during the quarter; * $0.9 million recognized as reduction to Direct Operation Expenses (“DOE”) and $0.2 million recognized as a reduction to general and administrative (“G&A”) expense year-to-date.OVERALL PERFORMANCEThe third quarter, along with the previous first half of 2020, presented the business with some of its toughest challenges to date. Most notably, the global spread of COVID-19 created unprecedented uncertainty and volatility in the oil and gas industry, particularly in the Western Canadian Sedimentary Basin. The demand for oil significantly deteriorated, as non-essential business around the globe, came to a grinding halt, and swiftly drove pricing into uneconomical territory, impacting the capital programs that drive a significant portion of Cordy’s business. Compounding the crisis, the Company had to quickly redesign its day to day business model, implementing new health and safety protocols, to mitigate the risk of contracting or spreading COVID-19 for our people, our customers, and their families.Despite the challenges, Cordy was able to manage through, what it believes was, the toughest stretch of 2020. The reopening of the economies around the globe has resulted in a return of oil and gas pricing to economical levels, and general business activity has started to slowly rebound as businesses and customers, adapt to the new rules of doing business in the COVID-19 era.OUTLOOK Operating results for the third quarter were encouraging, and management sees this trend continuing for the balance of 2020. In its Q2 outlook, management indicated that it believed the worst of the economic impact on the Company from COVID-19 appeared to have passed, and this continues to be management’s view. The timing of a full rebound in activity remains uncertain; however, the recent announcements of successful Phase 3 results, showing safe, effective coronavirus vaccines, provide optimism for the continuation of gradual recovery over the next six to twelve months.Despite the near-term market uncertainty resulting from the ongoing COVID-19 pandemic, the Company expects activity in the fourth quarter to continue to improve sequentially over the third quarter. Cordy’s oilfield customers reactivated drilling programs, albeit at a reduced level, early in the fourth quarter. If current market conditions persist, this trend is expected to continue through the end of the first quarter of 2021 based on current work programs.The company recognizes that any improvement in activity will be impacted by announced reductions in the Canada Emergency Wage Subsidy, which will likely impact overall margin. Furthermore, the uncertainty around the prolonged effects of COVID–19, the timing and availability of the vaccinations, and potential of strict lock-downs due recent surges in the number of active COVID-19 cases, are challenging to predict and any change in the current trends could significantly alter management’s expectations over the medium term.For the balance of 2020, and the foreseeable future, Cordy will continue to aggressively manage costs, while continuing to focus on the health and safety of its employees, contractors, and customers, ensuring it is doing its part in mitigating the spread, and limiting the impact of COVID-19.For general and investor relations information, please contact:Darrick Evong Chief Executive Officer IR@cordy.ca Tel: 403-262-7667 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.READER ADVISORYThis News Release contains certain statements that constitute forward-looking statements. These statements relate to future events or the Corporation’s future performance. All statements, other than statements of historical fact, that address activities, events or developments that the Corporation or a third party expects or anticipates will or may occur in the future, are forward-looking statements. These include the Corporation’s future growth, results of operations, performance and business prospects and opportunities; prevailing economic conditions; commodity prices; sourcing, pricing and availability of raw materials, components and parts, equipment, suppliers, facilities and skilled personnel; dependence on major customers; uncertainties in weather and temperature affecting the duration of the service periods and the activities that can be completed; regional competition; and other factors, many of which are beyond the Corporation’s control. These other factors include future prices of oil and natural gas and oil and natural gas industry activity, including the effect of changes in commodity prices on oil and natural gas exploration and development activity, the ability to complete strategic acquisitions and realize the anticipated benefits of any acquisitions that are completed, the Corporation’s outlook regarding the competitive environment it operates in, and the assumptions underlying any of the foregoing. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “predict”, “potential”, “targeting”, “intend”, “could”, “might”, “should”, “believe” and similar expressions. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the Corporation’s control, including those discussed under “Risks and Uncertainties” and elsewhere in this News Release, that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Corporation believes that the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this News Release should not be unduly relied upon. These statements speak only as of the date of this News Release. The Corporation does not intend, and does not assume any obligation, to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required under applicable securities laws. The forward-looking statements contained in this News Release are expressly qualified by this cautionary statement.